Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Overall survival vs disease-free survival and other surrogate endpoints - survival-analysis - Datamethods Discussion Forum
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Disease Free Survival - an overview | ScienceDirect Topics
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
What is Disease Free Survival (DFS) and Event Free Survival (EFS) in clinical trials?
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
Endpoints in adjuvant trials: a systematic review of the literature in colon cancer and proposed definitions for future trials Marc E. Buyse. - ppt download
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Association between event-free survival and overall survival in early-stage triple-negative breast cancer | Future Oncology
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
:max_bytes(150000):strip_icc()/GettyImages-697538653-59f6bf8dd963ac0010fa64a2.jpg "Understanding Event-Free Survival (EFS) After Treatment")
Understanding Event-Free Survival (EFS) After Treatment
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram
